Exhibit 23.1
| KPMG LLP Two Financial Center |
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 16, 2026, with respect to the consolidated financial statements of Stoke Therapeutics, Inc. and subsidiary, incorporated herein by reference, and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Boston, Massachusetts
March 18, 2026